Metabolic syndrome and its associated risk factors in Brazilian postmenopausal women

References

• Schneider J G, Tompkins C, Blumenthal R S, Mora S. The metabolic syndrome in women. Cardiol Rev 2006; 14: 286–291
   PubMedGoogle Scholar
• Ford E S, Giles W H, Dietz W H. Prevalence of the metabolic syndrome among US adults. Findings from the Third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356–359
   PubMed Web of Science ®Google Scholar
• NCEP Expert Panel on the detection, evaluation, and treatment of high blood pressure in adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP). Adult Treatment Panel III (ATP III). JAMA 2001; 285: 2444–2449
   Web of Science ®Google Scholar
• Millen B E, Pencina M J, Kimokoti R W, Meigs J B, Ordovas J M, D'Agostino R B. Nutritional risk and the metabolic syndrome in women: opportunities for preventive intervention from the Framingham Nutrition Study. Am J Clin Nutr 2006; 84: 434–441
   PubMed Web of Science ®Google Scholar
• Mosca L, Banka C L, Benjamin E J, et al. for the Expert Panel/Writing Group. Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women: 2007 Update. Circulation 2007; 115: 1481–1501
   PubMed Web of Science ®Google Scholar
• Sowers M F, Zheng H, Tomey K, et al. Changes in body composition in women over six years at midlife: ovarian and chronological aging. J Clin Endocrinol Metab 2007; 92: 895–901
   PubMed Web of Science ®Google Scholar
• Janssen I, Powell L H, Crawford S, Lasley B, Sutton-Tyrrell K. Menopause and the metabolic syndrome. The Study of Women's Health Across the Nation. Arch Intern Med 2008; 168: 1568–1575
   PubMed Web of Science ®Google Scholar
• Ding O F, Hayashi T, Zhang X J, et al. Risks of CHD identified by different criteria of metabolic syndrome and related changes of adipocytokines in elderly postmenopausal women. J Diabetes Compl 2007; 21: 315–319
   PubMed Web of Science ®Google Scholar
• IDF, International Diabetes Federation: the consensus worldwide definition of the metabolic syndrome, 2005. www.idf.org
   Google Scholar
• Mesch V R, Boero L E, Siseles N O, et al. Metabolic syndrome throughout the menopausal transition: influence of age and menopausal status. Climacteric 2006; 9: 40–48
   PubMed Web of Science ®Google Scholar
• Zhang C, Rexrode K M, van Dam R M, Li T Y, Hu F B. Abdominal obesity and the risk of all-cause, cardiovascular, and cancer mortality. Sixteen years of follow-up in US women. Circulation 2008; 117: 1658–1667
   PubMed Web of Science ®Google Scholar
• Grundy S M, Brewer H B, Jr, Cleeman J I, et al. Definition of metabolic syndrome: report of the National Heart, Lung and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition. Circulation 2004; 109: 433–438
   PubMed Web of Science ®Google Scholar
• Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes and inflammation. Circulation 2005; 111: 1448–1454
   PubMed Web of Science ®Google Scholar
• Ridker P M. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003; 107: 363–369
   PubMed Web of Science ®Google Scholar
• Obunai K, Jani S, Dangas G D. Cardiovascular morbidity and mortality of the metabolic syndrome. Med Clin North Am 2007; 91: 1169–1184
   PubMed Web of Science ®Google Scholar
• Lann D, LeRoith D. Insulin resistance as the underlying cause for the metabolic syndrome. Med Clin North Am 2007; 91: 1063–1077
   PubMed Web of Science ®Google Scholar
• Royer M, Castelo-Branco C, Blümel J E, et al. for the Collaborative Group for Research of the Climacteric in Latin America. The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III): prevalence of the metabolic syndrome in postmenopausal Latin American women. Climacteric 2007; 10: 164–170
   PubMed Web of Science ®Google Scholar
• Santos A C, Lopes C, Barros H. Prevalence of metabolic syndrome in the city of Porto. Rev Port Cardiol 2004; 23: 45–52
   PubMedGoogle Scholar
• Zabetian A, Hadaegh F, Azizi F. Prevalence of metabolic syndrome in Iranian adult population, concordance between the IDF with the ATPIII and the WHO definitions. Diabetes Res Clin Pract 2007; 77: 251–257
   PubMed Web of Science ®Google Scholar
• Ford E S. Prevalence of the metabolic syndrome by the International Diabetes Federation among adults in the US. Diabetes Care 2005; 28: 2745–2749
   PubMed Web of Science ®Google Scholar
• Silveira I L, Maranhão T MO, Azevedo G D. Metabolic syndrome in postmenopausal women: higher prevalence in the Northeastern Region of Brazil than in other Latin American countries and the influence of obesity and socioeconomic factors. Climacteric 2007; 10: 438–441
   PubMed Web of Science ®Google Scholar
• Piegas L S, Avezum A, Pereira J C, et al. Risk factors for myocardial infarction in Brazil. Am Heart J 2003; 146: 331–338
   PubMed Web of Science ®Google Scholar
• Lobo R A. Metabolic syndrome after menopause and the role of hormones. Maturitas 2008; 20(60)10–18
   Google Scholar
• Orchard T J, Temprosa M, Goldberg R, et al. The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: The Diabetes Prevention Program Randomized Trial. Ann Intern Med 2005; 142: 611–619
   PubMed Web of Science ®Google Scholar
• Deibert P, König D, Vitolins M Z, et al. Effect of a weight loss intervention on anthropometric measures and metabolic risk factors in pre- versus postmenopausal women. Nutr J 2007; 6: 31–38
   PubMedGoogle Scholar
• Skouby S O, Sidelmann J J, Nilas L, Gram J, Jespersen J. The effect of continuous combined conjugated equine estrogen plus medroxyprogesterone acetate and tibolone on cardiovascular metabolic risk factors. Climacteric 2008; 11: 489–497
   PubMed Web of Science ®Google Scholar
• Salpeter S R, Walsh J ME, Ormiston T M, Greyber E, Buckley N S, Salpeter E E. Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women. Diabetes, Obes Metab 2006; 8: 538–554
   PubMed Web of Science ®Google Scholar
• Chu M C, Cosper P, Nakhuda G S, Lobo R A. A comparasion of oral and transderaml short-term estrogem therapy in postmenopausal women with metabolic syndrome. Fertil Steril 2006; 86: 1669–1675
   PubMed Web of Science ®Google Scholar
• Windler E, Zyriax B C, Eidenmüller E, Boeing H. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study (a case-control study on women with incident coronary heart disease). Maturitas 2007; 57: 239–246
   PubMed Web of Science ®Google Scholar
• Welsh P, Woodward M, Rumley A, Lowe G. Associations of plasma pro-inflammatory cytokines, fibrinogen, viscosity and C-reactive protein with cardiovascular risk factors and social deprivation: the fourth Glasgow MONICA study. Br J Haematol 2008; 141: 852–861
   PubMed Web of Science ®Google Scholar
• Barinas-Mitchell E, Cushman M, Meilahn E N, Tracy R P, Kuller L H. Serum levels of C-reactive protein are associated with obesity, weight gain and hormone replacement therapy in healthy postmenopausal women. Am J Epidemiol 2001; 153: 1094–1101
   PubMed Web of Science ®Google Scholar
• Piché M E, Lemieux S, Weisnagel S J, Corneau L, Nadeau A, Bergeron J. Relation of high sensitivity C-protein, interleukin-6, tumor necrosis factor-alpha, and fibrinogen abdominal adipose tissue, blood pressure, and cholesterol and triglyceride levels in healthy postmenopausal women. Am J Cardiol 2005; 96: 92–97
   PubMed Web of Science ®Google Scholar
• Rutter M K, Meigs J B, Sullivan L M, D'Agostino R B, Wilson P W. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation 2004; 110: 380–385
   PubMed Web of Science ®Google Scholar
• Bo S, Gentile L, Ciccone G, et al. The metabolic syndrome and high C-reactive protein: prevalence and differences by sex in a southern-European population-based cohort. Diabetes Metab Res Rev 2005; 21: 515–524
   PubMed Web of Science ®Google Scholar
• Timpson N J, Lawlor D A, Harbord R M, et al. C-reactive protein and its role in metabolic syndrome: mendelian randomisation study. Lancet 2005; 366: 1954–1959
   PubMed Web of Science ®Google Scholar
• Grundy S M, Hansen B, Smith S C, et al. Clinical management of metabolic syndrome: report of the National Heart, Lung and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition. Circulation 2004; 109: 551–556
   PubMed Web of Science ®Google Scholar
• Knowler W C, Barrett-Connor E, Fowler S E, et al. and Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393–403
   PubMed Web of Science ®Google Scholar